{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T10:46:54Z","timestamp":1789814814171,"version":"4.0.1"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Dermatol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1111\/ced.12933","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T08:27:20Z","timestamp":1476779240000},"page":"852-857","source":"Crossref","is-referenced-by-count":51,"title":["Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up"],"prefix":"10.1093","volume":"41","author":[{"given":"C.","family":"Dessinioti","sequence":"first","affiliation":[{"name":"First Department of Dermatology; Andreas Sygros Hospital; University of Athens; Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Zisimou","sequence":"additional","affiliation":[{"name":"First Department of Dermatology; Andreas Sygros Hospital; University of Athens; Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Tzanetakou","sequence":"additional","affiliation":[{"name":"First Department of Dermatology; Andreas Sygros Hospital; University of Athens; Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Stratigos","sequence":"additional","affiliation":[{"name":"First Department of Dermatology; Andreas Sygros Hospital; University of Athens; Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Antoniou","sequence":"additional","affiliation":[{"name":"First Department of Dermatology; Andreas Sygros Hospital; University of Athens; Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,10,18]]},"reference":[{"key":"10.1111\/ced.12933-BIB0001|ced12933-cit-0001","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.clindermatol.2013.11.006","article-title":"Hidradenitis suppurativa (acne inversa) as a systemic disease","volume":"32","author":"Dessinioti","year":"2014","journal-title":"Clin Dermatol"},{"key":"10.1111\/ced.12933-BIB0002|ced12933-cit-0002","unstructured":"Humira pre-filled pen, pre-filled syringe and vial http:\/\/www.medicines.org.uk\/emc\/medicine\/21201"},{"key":"10.1111\/ced.12933-BIB0003|ced12933-cit-0003","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/ced.12933-BIB0004|ced12933-cit-0004","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000228337","article-title":"The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa","volume":"219","author":"Zee","year":"2009","journal-title":"Dermatology"},{"key":"10.1111\/ced.12933-BIB0005|ced12933-cit-0005","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1365-2133.2006.07155.x","article-title":"Clindamycin and rifampicin combination therapy for hidradenitis suppurativa","volume":"154","author":"Mendon\u00e7a","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/ced.12933-BIB0006|ced12933-cit-0006","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000228334","article-title":"Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients","volume":"219","author":"Gener","year":"2009","journal-title":"Dermatology"},{"key":"10.1111\/ced.12933-BIB0007|ced12933-cit-0007","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jdv.12127","article-title":"Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients","volume":"28","author":"Bettoli","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/ced.12933-BIB0008|ced12933-cit-0008","first-page":"729","volume-title":"Dermatologic Surgery","author":"Hurley","year":"1989"},{"key":"10.1111\/ced.12933-BIB0009|ced12933-cit-0009","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/jid.2012.472","article-title":"Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study","volume":"133","author":"Canoui-Poitrine","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1111\/ced.12933-BIB0010|ced12933-cit-0010","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ced.12933-BIB0011|ced12933-cit-0011","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaad.2009.03.043","article-title":"Hidradenitis suppurativa and associated factors: still unsolved problems","volume":"61","author":"Matusiak","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ced.12933-BIB0012|ced12933-cit-0012","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/jid.2012.255","article-title":"Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota","volume":"133","author":"Vazquez","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1111\/ced.12933-BIB0013|ced12933-cit-0013","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaad.2014.04.001","article-title":"Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity","volume":"71","author":"Schrader","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ced.12933-BIB0014|ced12933-cit-0014","first-page":"385","article-title":"Hypopigmented cutaneous sarcoidosis responsive to minocycline","volume":"11","author":"Schmitt","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/ced.12933-BIB0015|ced12933-cit-0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archderm.137.1.69","article-title":"The use of tetracyclines for the treatment of sarcoidosis","volume":"137","author":"Bachelez","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/ced.12933-BIB0016|ced12933-cit-0016","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/jamadermatol.2013.4646","article-title":"Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study","volume":"149","author":"Drake","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1111\/ced.12933-BIB0017|ced12933-cit-0017","unstructured":"Oracea Summary of product characteristics www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Oracea_29\/WC500008121.pdf"},{"key":"10.1111\/ced.12933-BIB0018|ced12933-cit-0018","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1684\/ejd.2013.2213","article-title":"Dramatic reduction clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination","volume":"24","author":"Join-Lambert","year":"2014","journal-title":"Eur J Dermatol"},{"key":"10.1111\/ced.12933-BIB0019|ced12933-cit-0019","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/AAC.01081-09","article-title":"Continuous clindamycin infusion, an innovative approach to treating bone and joint infections","volume":"54","author":"Zeller","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/ced.12933-BIB0020|ced12933-cit-0020","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2125.2012.04292.x","article-title":"Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitis","volume":"74","author":"Bouazza","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/ced.12933-BIB0021|ced12933-cit-0021","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1179\/joc.2004.16.4.357","article-title":"Immunomodulating activity of rifampicin","volume":"16","author":"Ziglam","year":"2004","journal-title":"J Chemother"},{"key":"10.1111\/ced.12933-BIB0022|ced12933-cit-0022","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1096\/fj.12-222992","article-title":"Rifampin inhibits Toll-like receptor 4 signaling by targeting myeloid differentiation protein 2 and attenuates neuropathic pain","volume":"27","author":"Wang","year":"2013","journal-title":"FASEB J"},{"key":"10.1111\/ced.12933-BIB0023|ced12933-cit-0023","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","article-title":"Hidradenitis suppurativa: a comprehensive review","volume":"60","author":"Alikhan","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/ced.12933-BIB0024|ced12933-cit-0024","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1365-2133.2011.10765.x","article-title":"Immunohistological pointers to a possible role for cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hdiradenitis suppurativa\/acne inversa","volume":"166","author":"Emelianov","year":"2012","journal-title":"Br J Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fced.12933","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fced.12933","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ced.12933\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:43:24Z","timestamp":1676385804000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/41\/8\/852\/6621666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,18]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,12]]}},"URL":"https:\/\/doi.org\/10.1111\/ced.12933","archive":["Portico"],"relation":{},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10,18]]}}}